Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Royalty Pharma plc (RPRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 144 Form 144 - Report of proposed sale of securities:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "ROYALTY PHARMA REPORTS SECOND QUARTER 2023 RESULTS"
07/12/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/02/2023 144 Form 144 - Report of proposed sale of securities:
06/02/2023 144 Form 144 - Report of proposed sale of securities:
05/22/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "ROYALTY PHARMA REPORTS FIRST QUARTER 2023 RESULTS"
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/28/2023 8-K Quarterly results
03/15/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"ROYALTY PHARMA RAISES FULL YEAR 2023 GUIDANCE • Royalty Pharma now expects 2023 Adjusted Cash Receipts to be between $2,850 million and $2,950 million, excluding contributions from future transactions."
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A FMR LLC reports a 10% stake in ROYALTY PHARMA PLC
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.1% stake in Royalty Pharma plc Class A
02/09/2023 SC 13G/A ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 1.6% stake in Royalty Pharma plc
01/09/2023 8-K Quarterly results
12/01/2022 8-K Quarterly results
11/22/2022 APP ORDR Form APP ORDR - 40-APP Order:
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "ROYALTY PHARMA REPORTS THIRD QUARTER 2022 RESULTS"
10/31/2022 APP NTC Form APP NTC - 40-APP Notice:
10/04/2022 SC 13D/A Giuliani Mario Germano reports a 10% stake in Royalty Pharma plc
10/03/2022 8-K Quarterly results
09/20/2022 40-APP Form 40-APP - Application for exemption and other relief filed under the Investment Company Act of 1940:
08/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "ROYALTY PHARMA REPORTS SECOND QUARTER 2022 RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy